Expert Perspectives 2024: Biologics for Management of COPD with MeiLan K Han, MD, MS
The GOLD report committee member highlights advances in knowledge of COPD phenotypes and the new role for biologic medications in this year's video series.
Antiobesity Drugs May Help Curb Alcohol Consumption: Daily Dose
Your daily dose of the clinical news you may have missed.
The Biggest Challenge with COVID-19 Right Now: An Interview with NFID Medical Director Robert Hopkins, Jr, MD
Hopkins, of the National Foundation for Infectious Diseases, is frustrated by the diminished societal response to the virus' circulation including ongoing low vaccination rates.
The Evolving Perception and Utilization of Antiobesity Drugs: Expert Discussion
Donna Ryan, MD, highlights how the media has helped to reframe obesity as a chronic disease and how antiobesity drugs are transforming metabolic disease treatment.
Safety of Moderna’s mRNA RSV Vaccine for Infants Heads Dec 12 VRBPAC Meeting Agenda
Moderna paused clinical research on the pediatric shot indefinitely in September after reports in July of severe adverse reactions in infants aged 5 to 8 months.
Upadacitinib Safe and Effective for Atopic Dermatitis in Adolescents at 76 Weeks: RCT Analysis
Upadacitinib (15 and 30 mg) was evaluated in adolescents with moderate to severe AD aged 12 to 17 years, with and without topical corticosteroids.
Most US Adults Want Primary Care Physicians to Address Mental Health: Daily Dose
Acupuncture and Sciatica: Impact on Pain and Function in Middle-Aged Adults
The efficacy of acupuncture treatment for chronic pain is still widely debated. A new study evaluated its effect on one of the most treatment resistant forms of low back pain.
Atogepant Improves QoL, Function in Adults with Chronic, Episodic, Treatment-Resistant Migraine
An analysis of patient reported outcome measures from 3 pivotal phase 3 RCTs of atogepant 60 mg demonstrates efficacy across functional domains as well as for migraine prevention.
Pivotal Obesity Trials in 2024: A Conversation with Donna Ryan, MD
Donna Ryan, MD, discusses the most significant clinical trials published this year in the field of obesity medicine.
10 More Can't Miss Doctor Gifts Worth Giving...or Having
An MDF stethoscope with leopard print tubing? A digital highlighter/scanner that translates and talks back? Check out these and 8 more uncommon gifts for health care professionals.
Online UTI Myths Found Common, Dangerous: Daily Dose
New COVID-19 Vaccination Guidance for Older Adults & High-Risk Groups: A Conversation with NFID Medical Director Robert Hopkins, Jr, MD
Guidance from the Advisory Committee on Immunization Practices on best practices for COVID-19 vaccination continues to evolve, Hopkins explained.
FDA Accepts GSK’s Submission for Use of Mepolizumab in COPD
The Prescription Drug User Fee Act date is set for May 7, 2025.
More than Half of US Adults Eligible for Semaglutide: Daily Dose
Americans Rate US Health Care at All-Time Low: A Gallup Survey Snapshot
Americans' rating of the quality of health care available in the US has hit its lowest in 24 years, according to a new Gallup survey; here's what they think.
Preventing Colon Cancer Before It Starts: Researchers Explore Novel Therapeutic Strategies
William Grady, MD, talks about the latest research in colorectal cancer, including treatments targeting senescent cells that contribute to tumor formation.
NFID Medical Director Highlights ACIP Rationale for Lowering Age for Pneumococcal Vaccination
Under risk-based guidelines, less than 30% of eligible adults are vaccinated against pneumococcal disease, said Robert Hopkins, Jr, MD. More details, here.
Influenza Antiviral Treatment Underutilized Among Vulnerable Youth: Daily Dose
Fremanezumab Safe and Effective for Prevention of Episodic Migraine in Children: Phase 3 Data Announced
The CGRP inhibitor fremanezumab reduced both monthly migraine and monthly headache days among children aged 6 to 17 years with a favorable safety profile.
